ORBIMED ADVISORS LLC - 16 Jun 2025 SCHEDULE 13D/A Report for Enliven Therapeutics, Inc. COMMON STOCK (ELVN)

Filing Manager
ORBIMED ADVISORS LLC
Reporting Manager
ORBIMED ADVISORS LLC
Security
Enliven Therapeutics, Inc. COMMON STOCK
Symbol
ELVN
Shares outstanding
59,090,769 shares
Disclosed Ownership
7,918,163 shares
Ownership
13%
Form type
SCHEDULE 13D/A
Filing time
17 Jun 2025, 17:30:13 UTC
Date of event
16 Jun 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
ORBIMED ADVISORS LLC 13% 7,918,163 0 7,918,163 /s/ Carl L. Gordon Carl L. Gordon, Member 0001055951
ORBIMED CAPITAL GP VII LLC 13% 7,663,349 0 7,663,349 /s/ Carl L. Gordon Carl L. Gordon, Member of OrbiMed Advisors LLC 0001760648
ORBIMED GENESIS GP LLC 0.4% 254,814 0 254,814 /s/ Carl L. Gordon Carl L. Gordon, Member of OrbiMed Advisors LLC 0001808744
ORBIMED CAPITAL LLC 0.1% 41,375 41,375 0 /s/ Carl L. Gordon Carl L. Gordon, Member 0001157524